- Home
- Services
- usa wyoming
- therapeutics launches gene therapy development
Show results for
Refine by
Therapeutics Launches Gene Therapy Development Services Available In Usa Wyoming
19 services found
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Antibody drugs which consist of antibody substances are prepared by antibody engineering technology based on cell and gene engineering technology. An important feature of antibody drugs is that they can be tailored making by genetic engineering and be prepared according to specific therapeutic needs. With the development of antibody genetic engineering technology, development of genetic ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
Our therapeutics are developed in house by a team of doctorate-level translational and discovery scientists, working hand-in-hand with clinicians, patients and thought leaders in each therapeutic ...
Manufactured by:Rocket Pharmaceuticals, Inc. based inCranbury, NEW JERSEY (USA)
Rocket’s Research and Discovery group in the Cranbury, New Jersey facility utilizes approximately 20,000 square feet of state-of-the-art laboratories for designing, optimizing and advancing candidate therapeutics to clinical stage ...
by:Synthego based inMenlo Park,, CALIFORNIA (USA)
For CRISPR-based therapies, understanding the potential and actual off-target edits associated with your CRISPR drug components is critical to their safety and efficacy. Synthego has partnered with SeQure Dx, a leading off-target editing analysis company, to bring you best-in-class OTE analysis for your RUO-to-GMP gRNAs. Whether you are deciding among several gRNAs, characterizing your final ...
by:Vertex Pharmaceuticals based inBoston, MASSACHUSETTS (USA)
Vertex is focused on discovering, developing and commercializing innovative medicines so people with serious diseases can lead better lives. Our scientists don’t see the impossible as an obstacle; they see it as a good place to start. These studies are investigating treatments or outcomes that have not all received approval from a health authority. The information presented is not intended ...
Manufactured by:ACROBiosystems based inNewark, DELAWARE (USA)
Biomolecular interaction analysis is used increasingly in drug development to kinetically characterize binding events of relevant components, including drugs and targets, antibodies and antigens or any pair of interacting molecules. Based on the Biacore 8K and ForteBio Octet platforms, ACROBiosystems provides biopharmaceutical R&D customers with complementary molecular interaction analysis ...
Manufactured by:Ariana Pharma based inParis, FRANCE
Using our pioneering eXplainable AI platform KEM® we design and execute Precision Medicine clinical trials, with an unparalleled successful track record across multiple therapeutic areas. Thanks to our XAI KEM® platform we integrate extensive pre-clinical, clinical as well as Real World Evidence data, to define best dose, identify patient selection and surrogate endpoint biomarkers as ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Antibody characterization is important in research and biopharmaceutical development. All therapeutic proteins produced from current technologies have heterogeneities in the final product because various modifications occur during different stages of production. Due to these heterogeneities, thorough characterization is necessary for the reproducible and safe production of therapeutic ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Creative Biolabs has extensive experience to offer the novel human or humanized antibody services for either therapeutic or laboratory applications. We have three routes in developing human antibodies. The first and most straightforward method is to screen our human antibody libraries. The second method is to immunize premade “humanized” mice and then raise hybridoma cell lines [or to ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunogram, Veracyte’s advanced analytics platform, integrates multi-omic data sets and analyzes them into a single per patient view of key biomarker signatures, specific to their own Tumor Microenvironment. This analytics platform delivers valuable insights to improve patient care and help clinical researchers make informed decisions to advance therapeutic and diagnostic ...
Manufactured by:Absolute Antibody Ltd based inRedcar, UNITED KINGDOM
Polyclonal antibodies are widely used reagents across research and diagnostics. They are generated by immunizing animals with an immunogen and harvesting the animals’ blood to obtain immunoreactive serum. While polyclonal antibodies offer a range of advantages such as excellent performance across different methods, they suffer from high batch-to-batch variability and require the continued ...
Manufactured by:MuseChem based inPaoli, PENNSYLVANIA (USA)
Bioconjugation is a strategy to form a stable covalent bond between two molecules, at least one of which is a biomolecule. As a cross-linking technique, bioconjugation has been widely used to create functional biomolecules for specific biomarkers imaging, cellular events tracking, protein biodistribution determination, enzyme function revealing and drug ...
Manufactured by:Entero Therapeutics, Inc. based inBoca Raton, FLORIDA (USA)
Latiglutenase, known as IMGX003, is an orally administered formulation comprising two recombinant proteases specifically targeting gluten proteins. It works by breaking down these proteins into smaller, non-reactive fragments, offering an adjunctive measure to a gluten-free diet for managing celiac disease. This autoimmune disorder affects the small intestine and is triggered by dietary gluten ...
Manufactured by:Aviva Systems Biology Corporation based inSan Diego, CALIFORNIA (USA)
Aviva provides customized solutions to each protein expression project. Our expert scientific staff has experience with difficult proteins and have produced more than 2,500 recombinant proteins. Whether your needs are small scale research or large scale cGMP, we can apply our experience to meet your needs. Services include E. coli expression, Mammalian expression, Yeast expression, and Antigen ...
Manufactured by:Bio-Rad Laboratories, Inc. (Antibodies) based inHercules, CALIFORNIA (USA)
Reduce Lead Time for Antibody Generation: Assays supporting SARS-CoV-2 vaccine, therapeutic, and diagnostic test development must be robust, scalable, and transferable to laboratories worldwide. They need to be designed and validated rapidly, yet without compromising quality. We understand that critical antibody reagents for these vital assays must be highly specific for the chosen antigen, ...
by:Cmbio based inCopenhagen, DENMARK
The gut microbiome is central to digestive health and metabolic processes, influencing conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and metabolic disorders like obesity and diabetes. At Cmbio, we offer multi-omics solutions to explore the connections between the gut microbiome, digestion, and metabolism. Our tools provide actionable insights to drive ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...
by:SoBran Inc. based inFairfax, VIRGINIA (USA)
Our scientific and technical experts assemble customized research programs with attention to your specific project requirements, timelines and budget. To support small animal preclinical toxicology and drug discovery, we offer an expanding range of services that meet GLP and non-GLP compliant in vivo research requirements. Program management is certified to the ISO 9001:2008 standard. ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal and healthy tissue. Streamlined development, evaluation and clinical translation of radiopharmaceuticals requires a partner that has extensive ...